Effect of recombinant activated factor VII a on early recovery of patients undergoing cardiac valve replacement under cardiopulmonary bypass: A randomized double-blind placebo-controlled trial

Academic Journal of Second Military Medical University

Volumn 27, Issue 10, 2006, Pages 1110-1113

  Ma, Bin ^a   Wang, Zhi Nong ^a   Zhang, Bao Ren ^a   Xu, Zhi Yun ^a   Yang, Li Xin ^a   Chen, Ke Biao ^a   Li, Jian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Blood coagulation; Blood transfusion; Cardiopulmonary bypass; Recombinant factor VII a

Indexed keywords

BATROXOBIN; ETAMSYLATE; HEMOSTATIC AGENT; HEPARIN; PLACEBO; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING; BLOOD SAMPLING; BLOOD TRANSFUSION; BRAIN INFARCTION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG FATALITY; FEMALE; HEART INFARCTION; HEART VALVE REPLACEMENT; HEMOSTASIS; HEPARINIZATION; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MALE; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; THORAX DRAINAGE; TREATMENT OUTCOME;

EID: 33750442925     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Engoren MC, Habib RH, Zacharias A. Effect of blood transfusion on long-term survival after cardiac operation [J]. Ann Thorac Surg, 2002, 74: 1180-1186.
2. Mayer SA, Brun NC, Broderick J, et al. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage [J]. Stroke, 2005, 36: 74-79.
3. Friederih PW, Henny CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomized trial [J]. Lancet, 2003, 361: 201-205.
4. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review [J]. Intensive Care Med, 2004, 30: 1873-1881.
5. He S, Blombk M, Jacobsson Ekman G, et al. The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX [J]. Thromb Haemost, 2003,1: 1215-1219.
6. Roberts HR, Monroe DM, Escobar MA. Current concepts of hemostasis [J]. Anesthesiology, 2004, 100: 722-730.
7. Laffan M, O'Connell NM, Perry DJ, et al. Analysis and results of the recombinant factor VIIa extended-use registry [J]. Blood Coagul Fibrinolysis, 2003, 14(Suppl 1): S35-S38.
8. Bui JD, Despotis GD, Trulock EP, et al. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII [J]. Thorac Cardiovasc Surg, 2002, 124: 852-854.